FINWIRES · TerminalLIVE
FINWIRES

研究警示:CFRA维持对科慕公司股票的卖出评级

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们维持目标价12美元不变,基于6.0倍的预期市盈率,以及对2027年每股收益1.99美元的预期,该预期较五年平均水平有所折让,主要原因是短期基本面担忧和持续存在的诉讼问题。我们维持对2026年每股收益1.33美元和2027年每股收益1.99美元的预期不变。在科慕公司发布第一季度财报后,我们维持对该公司股票的“卖出”评级,因为我们认为该公司面临诸多诉讼问题带来的高风险,尤其是其卷入的PFAS诉讼,并且可能受到化学品监管加强的负面影响。科慕公司公布的净销售额为13.81亿美元(同比增长1%),各业务板块表现不一。尽管TSS业务板块表现强劲(同比增长22%),但仍不足以抵消TT业务板块(同比下降6%)和APM业务板块(同比下降17%)的下滑。华盛顿工厂的停产也限制了第一季度的产量,造成约2500万美元的负面影响,我们认为,这凸显了公司在整个生产布局中存在的运营执行风险。

Related Articles

Research

Research Alert: Dxc Sees Deteriorating Bookings, Provides Disappointing Fy 27 Outlook

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:DXC's Q4 FY 26 (Mar-Q) revenue of $3.13B declined 1.2% Y/Y (-6.6% organically), missing Street expectations of $3.15B, with DXY's FY 26 organic decline showing a continued downward acceleration to 4.8% from 4.6% in FY 25. Non-GAAP EPS of $0.77 beat consensus of $0.70 but declined by 8.3% Y/Y. Q4 bookings of $3.3B fell 13.5% Y/Y, offsetting the positive milestone of DXC's book-to-bill (1.07x) exceeding 1.0x for the first time since Q4 FY 25. We expect continued pressure as deteriorating bookings performance raises concerns about future revenue visibility. Management's FY 27 guidance suggests ongoing headwinds, with revenue expected to decline 3%-5% organically, non-GAAP EPS guided to $2.65 at the midpoint (well below expectations of $3.06), and FCF of $600M (-16% Y/Y) missing expectations for $662M. While the company emphasizes AI initiatives including its OASIS platform, we believe the extended timeline for meaningful contribution (10% of revenue by Q2 FY 29) provides limited support.

$DXC
Research

Research Alert: Net: Soft Guidance Offsets Q1 Beats; Announces Workforce Restructuring

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:NET delivered strong Q1 2026 results, with revenue of $639.8M (+34% Y/Y), beating consensus by $17.2M, while non-GAAP EPS of $0.25 improved 56% from $0.16 in the prior year, exceeding estimates by $0.02. Non-GAAP gross margins compressed to 72.8% from 77.1% Y/Y due to infrastructure investments for AI workloads, though operating leverage remained strong, with margins of 11.4% declining only 30 bps. Management announced a significant AI-first transformation, planning to reduce its workforce by ~1,100 people, with $140M-$150M in restructuring charges. For Q2 2026, NET expects revenue of $664M-$665M (~30% growth) with non-GAAP EPS of $0.27, while full-year guidance calls for $2,805M-$2,813M in revenue (~29% growth), below the Street's projections of $2,797M after incorporating the beat, and EPS of $1.19-1.20. Free cash flow surged 59% to $84.1M (13% of revenue), reflecting strong fundamentals, while the balance sheet remains robust with $4.16B in cash and securities.

$NET
Research

Research Alert: Draftkings Beats Estimates; Maintains Full-year Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:DKNG delivered solid Q1 results with revenue up 17% to $1.646B and positive GAAP net income of $21.1M vs. a $33.9M loss in the prior year, while adjusted EBITDA surged 64% to $167.9M. Sportsbook revenue jumped 24% to $1.095B with net revenue margin expanding 140 basis points to 7.8%, demonstrating enhanced pricing power and favorable sports outcomes. We are impressed with continued momentum in the company's profitability push but worry about stagnant monthly active user growth and execution in prediction markets. Management maintained 2026 guidance for revenue of $6.5B-$6.9B and adjusted EBITDA of $700M-$900M, emphasizing plans to invest aggressively in Sports Predictions. MUPs declined 4% to 4.2M due to the Texas lottery exit but increased 2% excluding lottery operations, while average revenue per MUP jumped 21% to $131. The company ended with $999.4M in cash and shares trade at 16x consensus 2026 EBITDA estimates.

$DKNG